Provention Bio Investor Relations Material
Latest events
FDA Announcement
Provention Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Provention Bio Inc
Access all reports
Provention Bio Inc. is a biopharmaceutical company focused on the development of therapies aimed at preventing and intercepting immune-mediated diseases, particularly in areas with significant unmet medical needs. The company specializes in immunology, working to create treatments that modulate the immune system to prevent the onset or progression of chronic diseases. Provention Bio collaborates with healthcare providers and research institutions to bring innovative therapeutic options to patients at risk of developing conditions with autoimmune components. The company is headquartered in Red Bank, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PRVB
Country
🇺🇸 United States